Skip to search
Skip to main content
Back to Search
Start Over
48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY
Authors :
Berg, T Shiffman, ML Zeuzem, S Berg, CP de Figueiredo-Mendes, C Dore, GJ Ferraz, ML Mendes-Correa, MC Lima, MP Parise, E Rios, AMP Reuter, T Sanyal, AJ Shafran, SD Hohmann, M Tatsch, F Cheinquer, H Berg, T Shiffman, ML Zeuzem, S Berg, CP de Figueiredo-Mendes, C Dore, GJ Ferraz, ML Mendes-Correa, MC Lima, MP Parise, E Rios, AMP Reuter, T Sanyal, AJ Shafran, SD Hohmann, M Tatsch, F Cheinquer, H
Publication Year :
2013
Details
Database :
OAIster
Notes :
1, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1031069006
Document Type :
Electronic Resource